| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $6.57 | - | - |
| Q1'26 | $5.57 | $5.80 | +4.1% |
| Q3'25 | $5.64 | $5.70 | +1.0% |
| Q2'25 | $5.12 | $5.13 | +0.1% |
| Q1'25 | $4.51 | $4.51 | -0.1% |
| Q4'24 | $5.35 | $5.36 | +0.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.3B | - | - |
| Q1'26 | $1.2B | $1.3B | +2.2% |
| Q3'25 | - | $1.2B | - |
| Q2'25 | - | $1.1B | - |
| Q1'25 | - | $1.0B | - |
| Q4'24 | - | $1.0B | - |
Market Data
CPAY is currently trading at $371.19, giving Corpay, Inc. a market cap of 23.28B and a P/E ratio of 19.8. Today's range spans $362.33–$372.25, with shares opening at $363.97 and moving up $8.03 (2.2%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 79/100.
Over the past year CPAY has traded between $252.84 and $367.43 - the current price is +46.8% off the 52-week low and +1.0% from the high. 24 analysts cover the stock with a Buy consensus and a mean 12-month target of $395.14 (range $340.00–$450.00), implying upside of +6.5%.
Cross-asset context supports the bullish read on CPAY: when Technology sector conditions are favorable, large-cap names with 95/100 technical scores (BUY) and bullish sentiment (79/100) outperform on a risk-adjusted basis. Price: $371.19 (near 52-week highs). (P/E: 19.8) The 52-week context of $252.84–$367.43 shows the full trading history - and the current setup is one of the stronger entries within that range. At 23.28B in market cap, position sizing is the key variable, not the direction.
The combination of a BUY signal (95/100) and bullish news sentiment (79/100) puts CPAY on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 23.28B in Technology market cap without immediately moving the stock. At $371.19 (near 52-week highs in the $252.84–$367.43 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).